Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin

BACKGROUND: T674I FIP1L1-PDGFRα in a subset of chronic eosinophilic leukemia (CEL) is a gatekeeper mutation that is resistant to many tyrosine kinase inhibitors (TKIs) (e.g., imatinib, nilotinib and dasatinib), similar to T315I Bcr-Abl. Therefore, novel TKIs effective against T674I FIP1L1-PDGFRα are...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yanli, Ding, Ke, Li, Honglin, Xue, Mengzhu, Shi, Xiaoke, Wang, Chengyan, Pan, Jingxuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928078/
https://www.ncbi.nlm.nih.gov/pubmed/24472312
http://dx.doi.org/10.1186/1476-4598-13-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928078/
https://www.ncbi.nlm.nih.gov/pubmed/24472312
http://dx.doi.org/10.1186/1476-4598-13-17

Ejemplares similares